E3 PreliminaryPreliminaryPEM ?Peer-reviewedMachine draft
Recovery from refractory chronic fatigue syndrome with CBT and modafinil.
Garg, Himanshu, Douglas, Maggie, Turkington, Gordon Douglas et al. · BMJ case reports · 2021 · DOI
Quick Summary
This small study looked at three patients with severe, long-lasting ME/CFS who had not improved with standard treatments. When doctors added a medication called modafinil to cognitive behavioral therapy (CBT), two of the three patients reported meaningful improvements in fatigue, pain, and concentration, and all three were able to return to work or study. This suggests that combining modafinil with CBT might help some treatment-resistant patients, though more research is needed.
Why It Matters
For severely disabled ME/CFS patients who have failed conventional treatments, this case series offers preliminary hope that medication augmentation of psychological therapy might facilitate functional recovery. The findings challenge treatment nihilism in refractory cases and suggest potential value in investigating modafinil as an adjunctive agent in adequately powered trials.
Observed Findings
- Two of three patients achieved ≥2-point improvements on 10-point Likert scales for energy and pain/concentration
- All three patients achieved social recovery, defined as return to work or full-time training
- Mean disease duration before treatment was 17.66 years
- Outcomes were tracked over 10-24 months of combined modafinil and CBT treatment
- Patients had previously failed to respond to standard evidence-based treatments
Inferred Conclusions
- Medium-term modafinil prescription may potentiate the benefits of CBT in treatment-resistant CFS
- Combination pharmacological and psychological approaches may facilitate social recovery in severely disabled patients
- Some patients with refractory CFS may benefit from repeated or optimized medication trials
Remaining Questions
- What is the optimal dose and duration of modafinil for ME/CFS patients?
- Which patient characteristics predict response to modafinil augmentation of CBT?
- Does modafinil alone (without CBT) provide similar benefits, or is the combination essential?
What This Study Does Not Prove
This study does not prove that modafinil causes recovery in ME/CFS, nor does it establish efficacy in the broader patient population. The very small sample size, lack of control or comparison group, retrospective methodology, and potential selection bias mean these findings cannot be generalized. Placebo effects, natural disease trajectory, and other concurrent life changes cannot be excluded as explanations for the observed improvements.
Tags
Symptom:Cognitive DysfunctionPainFatigue
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsSmall SampleExploratory Only
Metadata
- DOI
- 10.1136/bcr-2020-240283
- PMID
- 33753384
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026